https://biotechmorning.com/news/glp1-gold-rush-pothole-dr-reddys-semaglutide-delay Biotech Morning en 2026-07-27T14:26:55.531Z The GLP-1 Gold Rush Just Hit a Pothole https://biotechmorning.com/news/prime-medicine-beam-arbitration-gene-editing Biotech Morning en 2026-07-27T14:26:00.355Z Two Gene-Editing Companies Born in the Same Lab Just Went to War https://biotechmorning.com/news/allogene-allo-316-car-t-solid-tumors-breakthrough Biotech Morning en 2026-07-27T14:25:08.546Z The Cancer Therapy That Wasn't Supposed to Work in Solid Tumors https://biotechmorning.com/news/715-million-48-hours-two-bets-reshaping-biotech Biotech Morning en 2026-07-27T14:23:30.923Z $715 Million in 48 Hours: The Two Bets Reshaping Biotech https://biotechmorning.com/news/gsk-alector-neuroscience-collaboration-terminated Biotech Morning en 2026-07-27T14:22:35.305Z GSK Just Lit $700 Million on Fire in the Neuroscience Graveyard https://biotechmorning.com/news/europe-flu-covid-combo-vaccine-moderna Biotech Morning en 2026-07-27T14:21:43.638Z One Shot to Rule Them All: Europe's Bet on a Flu-COVID Combo Vaccine https://biotechmorning.com/news/astrazeneca-sino-biopharmaceutical-copd-drug-deal Biotech Morning en 2026-07-26T14:23:14.611Z AstraZeneca Just Paid $200M for a Chinese COPD Drug Most Investors Haven't Heard Of https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-4 Biotech Morning en 2026-07-26T14:22:23.832Z Gilead Just Dropped $5 Billion on a German Startup You've Never Heard Of https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition Biotech Morning en 2026-07-26T14:21:29.471Z Merck KGaA Just Dropped $11.3 Billion on a Company You've Probably Never Heard Of https://biotechmorning.com/news/congress-merck-abbvie-china-military-hospital-trials Biotech Morning en 2026-07-26T14:20:37.240Z Congress Wants to Know Why Merck and AbbVie Ran Drug Trials at Chinese Military Hospitals https://biotechmorning.com/news/gene-editing-breaks-two-year-ipo-drought Biotech Morning en 2026-07-26T14:19:50.401Z Gene Editing Just Broke a Two-Year IPO Drought https://biotechmorning.com/news/lab-grown-eggs-sperm-ivg-breakthrough-2026 Biotech Morning en 2026-07-26T14:18:53.123Z Two Startups Say They Can Make Babies Without Sex. From a Blood Draw. https://biotechmorning.com/news/ema-revokes-amgen-tavneos-data-integrity-2 Biotech Morning en 2026-07-26T14:17:59.175Z The $3.7B Drug That Europe Just Said Was Built on a Lie